Merriman Wealth Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,000	Closed	-$333K	–	189
2022 Q1	$333K	Buy	+5,000	New	+$333K	0.03%	150